Latest Regulatory Approvals News

Microba Life Sciences reveals breakthrough data showing its MetaPanel™ test detects elusive gastrointestinal pathogens in 20% of chronic cases, enabling targeted treatment and complete symptom resolution.

Gibb River Diamonds has inked a pivotal mining contract with BML Ventures to kickstart open pit gold mining at its Edjudina Project, aiming for production as early as August 2025.

Gold Road Resources has secured a crucial regulatory green light as the Foreign Investment Review Board approves Gold Fields’ acquisition scheme. The deal now moves closer to shareholder and court approvals.

Top End Energy has appointed New York-based Amvest Capital to spearhead its U.S. investor engagement and plans an American Depositary Receipt listing by Q3 2025, aiming to open doors to one of the world’s largest energy capital markets.

Tempest Minerals has enhanced geochemical sampling at its Sanity Prospect within the Yalgoo Project, confirming a robust gold anomaly and setting the stage for targeted drilling.

Minerals 260 has agreed to sell its Aston Lithium-REE Project to Delta Lithium for $450,000 cash plus a 1.5% royalty, redirecting its efforts toward advancing the 2.3 million ounce Bullabulling Gold Project in Western Australia.

Duketon Mining has advanced exploration activities at its Killarney and Barlee gold projects, with new sampling and drilling programs underway pending approvals.

Renergen Limited is poised to be acquired by US-based ASP Isotopes Inc. in a deal that aims to create a powerhouse in critical helium and isotope supply chains. The merger promises expanded market access and strategic value across key industries.

ASPI Isotopes Inc. has agreed to acquire Renergen Limited in an all-share deal, creating a vertically integrated global entity focused on critical materials for semiconductors, medical isotopes, and green energy. The transaction addresses Renergen’s liquidity challenges and positions the combined company for growth across multiple strategic sectors.

Macarthur Minerals has secured $250,000 through unsecured convertible notes to bolster its working capital and support ongoing operations amid challenging market conditions.

Kingston Resources has agreed to sell its Misima Gold-Silver Project for $95 million, bolstering its balance sheet to accelerate growth at the Mineral Hill gold-copper operation. The transaction positions Kingston to expand production and exploration in the southern Cobar Basin.

Clarity Pharmaceuticals has initiated its second registrational Phase III AMPLIFY trial for the Cu-SAR-bisPSMA PET imaging agent targeting biochemical recurrence of prostate cancer. The multi-centre study aims to generate critical data supporting FDA approval and could redefine prostate cancer diagnostics.